SV112 Delivery™ Lipid Nanoparticle R&D

A biotechnology company located in the Greater Boston area specializes in the development of advanced lipid nanoparticle (LNP) delivery systems and self-amplifying mRNA (samRNA) platforms. Leveraging a proprietary library of more than one million molecular structures, over 60,000 ionizable lipids have been synthesized and screened using high-throughput technologies.

To accelerate progress in the mRNA research community, a series of ready-to-use LNP kits have been launched in research use only for proof-of-concept and screening mRNA constructs in vitro/in vivo.

Features:
· Simple and rapid use —just mix your mRNA with the formulation/lipid mixture for immediate in vitro application or concentrate for in vivo use.
· High encapsulation efficiency (EE>90%), consistent particle size (~100nm), and robust transfection performance.
· Ideal for labs and researchers lacking specialized LNP formulation expertise or equipment.
· Excellent for proof-of-concept studies, mRNA screening, and early-stage research.

These kits embody an "instant coffee"—like convenience—streamlining LNP-mRNA delivery for researchers.

Please contact us at for specific academic pricing.